Name

MVT

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for MVT

Name

Alternate Names

CL 232315
Mitoxantrone Hydrochloride
Mitozantrone
Novantrone

Abbreviations

DAD
DHAD
DHAQ

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

301739

Primary Site

Breast
Non-Hodgkin lymphoma
Prostate- advanced hormone-refractory

Histology

None

Remarks

Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione

Coding

This drug should be coded

Name

Alternate Names

Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar

Abbreviations

EPEG
VP-16
VP-16-213

Category

Chemotherapy

Subcategory

Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid

NSC Number

141540

Primary Site

Gastric cancer
Hodgkins lymphoma
Lung cancer (NSCLC, SCLC)
Non-Hodgkin lymphoma
testicular cancer (Germ cell tumors)

Histology

None

Remarks

Plant alkaloid. FDA approved use on small-cell lung cancer, testicular cancer.

Coding

This drug should be coded

Name

Alternate Names

Oncotepa
Oncotiotepa
Tepa
Tespa
Tespa-min
Tespamine
Thio
Thio-tepa
Thiofozil
Thiophosphamide
Thioplex
Thiotef
Tifosyl
Tio-TEF
Tiofosfamid
Tiofosyl (Sweden)
Tiofozil
Triethylene thiophosphoramide
WR-45312

Abbreviations

STEPA
TESP
TESPA
Thio-TEPA
TSP
TSPA

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

006396
6396

Primary Site

None

Histology

None

Remarks

Cell cycle nonspecific chemotherapeutic agent. FDA approved uses on intravesicular bladder carcinoma, breast adenocarcinoma, malignant intracavitary effusions, Hodgkin's lymphoma, lymphosarcoma, and ovarian adenocarcinoma. Alkylating agent.

Coding

This drug should be coded
Glossary